Third degree AV block echocardiography and ultrasound: Difference between revisions

Jump to navigation Jump to search
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Third degree AV block}}
{{Third degree AV block}}
{{CMG}}; {{AE}} {{Soroush}}
{{CMG}}; {{AE}} {{Sara.Zand}} {{Soroush}}
==Overview==
==Overview==
 
[[Echocardiography]] is useful for evaluation of underlying [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[conduction abnormality]]. Common indications for [[echocardiography]] in suspicion of [[cardiac origin]] of [[bradycardia]] or [[conduction disorder]] may include [[syncope]], [[lightheadedness]]/[[presyncope]], [[symptoms]] related to [[aortic stenosis]], [[hypertrophic  cardiomyopathy]], [[heart  failure]].
[[Transthoracic echocardiography]] may be helpful in the diagnosis of the underlying diseases tend to third degree AV block. An echocardiography might show shreds of evidence in favor of [[cardiomyopathy|cardiomyopathies]] and/or [[valvular heart disease]]s . In special case scenarios, [[Transesophageal echocardiogram|transesophageal echocardiography]] is warranted and may help to diagnose etiologies such as valvular ring abscess. Furthermore, the left ventricular function can be determined using an echo, and provide evidences in favor of the placement of a [[pacemaker]] or [[defibrillator]].


==[[Echocardiography]]==
==[[Echocardiography]]==
*[[Echocardiography]] is useful for evaluation of underlying [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[conduction abnormality]].
[[Echocardiography]] is useful for evaluation of underlying [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[conduction abnormality]] including [[cardiomyopathy]], [[valvular heart disease]], [[congenital]] anomalies, [[tumors]], [[infections]], [[infiltrative processes]], [[immunologically]] mediated [[conditions]], and diseases of the [[great vessels]] and [[pericardium]].
* Common indications for [[echocardiography]] in suspicion of [[cardiac origin]] of [[bradycardia]] or [[conduction disorder]] may include:
* Common indications for [[echocardiography]] in suspicion of [[cardiac origin]] of [[bradycardia]] or [[conduction disorder]] may include:
* [[Syncope]]
:* [[Syncope]]
* [[Lightheadedness]]/[[presyncope]]
:* [[Lightheadedness]]/[[presyncope]]
* [[Symptoms]] related to [[aortic stenosis]], [[hypertrophic  cardiomyopathy]], [[heart  failure]]
:* [[Symptoms]] related to [[aortic stenosis]], [[hypertrophic  cardiomyopathy]], [[heart  failure]]




Line 18: Line 17:
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |'''Recommendations for Echocardiography in  Bradycardia or Conduction disorder'''
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |'''Recommendations for Echocardiography in  Bradycardia or Conduction disorder'''
|-
|-
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Medical therapy ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]]):'''
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''[[Echocardiography]] ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]]):'''
|-
|-
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left|
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left|
Line 46: Line 45:
<br>
<br>
{|
{|
! colspan="2" style="background: PapayaWhip;" align="center" + |The above table adopted from 2018 AHA/ACC/HRS Guideline
! colspan="2" style="background: PapayaWhip;" align="center" + |The above table adopted from 2018 AHA/ACC/HRS Guideline<ref name="KusumotoSchoenfeld2019">{{cite journal|last1=Kusumoto|first1=Fred M.|last2=Schoenfeld|first2=Mark H.|last3=Barrett|first3=Coletta|last4=Edgerton|first4=James R.|last5=Ellenbogen|first5=Kenneth A.|last6=Gold|first6=Michael R.|last7=Goldschlager|first7=Nora F.|last8=Hamilton|first8=Robert M.|last9=Joglar|first9=José A.|last10=Kim|first10=Robert J.|last11=Lee|first11=Richard|last12=Marine|first12=Joseph E.|last13=McLeod|first13=Christopher J.|last14=Oken|first14=Keith R.|last15=Patton|first15=Kristen K.|last16=Pellegrini|first16=Cara N.|last17=Selzman|first17=Kimberly A.|last18=Thompson|first18=Annemarie|last19=Varosy|first19=Paul D.|title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society|journal=Circulation|volume=140|issue=8|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000628}}</ref>
|-  
|-  
|}
|}

Latest revision as of 07:49, 11 July 2021

Third degree AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Third degree AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Third degree AV block echocardiography and ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Third degree AV block echocardiography and ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Third degree AV block echocardiography and ultrasound

CDC on Third degree AV block echocardiography and ultrasound

Third degree AV block echocardiography and ultrasound in the news

Blogs on Third degree AV block echocardiography and ultrasound

Directions to Hospitals Treating Third degree AV block

Risk calculators and risk factors for Third degree AV block echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3]

Overview

Echocardiography is useful for evaluation of underlying structural heart disease in patients presented with bradycardia or conduction abnormality. Common indications for echocardiography in suspicion of cardiac origin of bradycardia or conduction disorder may include syncope, lightheadedness/presyncope, symptoms related to aortic stenosis, hypertrophic cardiomyopathy, heart failure.

Echocardiography

Echocardiography is useful for evaluation of underlying structural heart disease in patients presented with bradycardia or conduction abnormality including cardiomyopathy, valvular heart disease, congenital anomalies, tumors, infections, infiltrative processes, immunologically mediated conditions, and diseases of the great vessels and pericardium.


Recommendations for Echocardiography in Bradycardia or Conduction disorder
Echocardiography (Class I, Level of Evidence B):

Echocardiography is recommended in patients with newly identified LBBB, second-degree Mobitz type II atrioventricular block, high-grade atrioventricular block, or third-degree atrioventricular block with or without apparent structural heart disease or coronary artery disease

Echocardiography ( Class IIa, Level of Evidence B) :

Echocardiography is recommended in suspicion of structural heart disease in patients presented with bradycardia or conduction disorders other than LBBB, second-degreeMobitz type II atrioventricular block, high-grade atrioventricular block, or third-degree atrioventricular block

Advanced imaging : (Class IIa, Level of Evidence C)

❑ In suspicion of structural heart disease in patients presented with bradycardia or bundle branch block, transesophageal echocardiography, computed tomography, cardiac magnetic resonance imaging (MRI),or nuclear imaging is recommended

Cardiac imaging : (Class III, Level of Evidence B)

❑ Routine cardiac imaging is not recommended in patients with asymptomatic sinus bradycardia or first-degree atrioventricular block and no clinical evidence of structural heart disease

Abbreviations: PPM: Permanent pacemaker; LBBB: Left bundle branch block

The above table adopted from 2018 AHA/ACC/HRS Guideline[1]

References

  1. Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.

Template:WH Template:WS